Company Filing History:
Years Active: 2014
Title: Innovations of Henrik Ostergaard
Introduction
Henrik Ostergaard is a notable inventor based in Lyngby, Denmark. He has made significant contributions to the field of engineered proteins, particularly through his innovative patent. His work is recognized for its potential applications in biotechnology and pharmaceuticals.
Latest Patents
Henrik Ostergaard holds a patent titled "Selective reduction and derivatization of engineered proteins comprising at least one non-native cysteine." This invention relates to a method for the selective reduction and derivatization of recombinantly prepared engineered proteins that contain at least one non-native cysteine. The reduction reaction is conducted in the presence of a redox buffer or a triarylphosphine reducing agent. This patent showcases his expertise in protein engineering and biochemistry.
Career Highlights
Henrik Ostergaard is associated with Novo Nordisk Healthcare AG, a leading global healthcare company. His role at the company allows him to work on cutting-edge research and development in the field of healthcare and biotechnology. His contributions have been instrumental in advancing the understanding and application of engineered proteins.
Collaborations
Henrik has collaborated with esteemed colleagues such as Anders Klarskov Petersen and Soren E Bjorn. These collaborations have fostered a productive environment for innovation and research in their respective fields.
Conclusion
Henrik Ostergaard's work exemplifies the spirit of innovation in biotechnology. His patent on engineered proteins highlights his significant contributions to the field. His collaborations and career at Novo Nordisk Healthcare AG further underscore his impact on healthcare advancements.